Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039277
Filing Date
2022-02-14
Accepted
2022-02-14 06:51:00
Documents
2
Group Members
GILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS X, LLCKEVAL DESAIKHALED A. NASR

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d313482dsc13ga.htm SC 13G/A 98780
2 EX-99.A d313482dex99a.htm EX-99.A 5039
  Complete submission text file 0001193125-22-039277.txt   105447
Mailing Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022
Business Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

EIN.: 263131621 | State of Incorp.: CA
Type: SC 13G/A

Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 22625014
SIC: 2834 Pharmaceutical Preparations